MoonLake Immunotherapeutics (MLTX) Q2 2025 Earnings

May 12Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.75
-0.59
-0.44
-0.28

Details

Expected EPS
-0.75393
Actual EPS
-0.63
Surprise EPS
0.12
Surprise Percent
+16.44%

Description

⁨MoonLake Immunotherapeutics⁩ (⁦MLTX⁩) has reported earnings of ⁦-0.63⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts